MR COOPER GROUP COOP 深 沪
已收盘 08-01 16:00:00 美东时间
174.26
+18.540
+11.91%
华盛通- 最 高180.5745
- 今 开163.72
- 成交量 206.23万股
- 最 低 163.35
- 昨 收 155.72
- 总市值 111.50亿
- 52周最高 180.5745
- 市盈率 静 17.11
- 换手率 3.22%
- 52周最低 84.1501
- 委 比 -55.56%
- 总股本 6398.54万
- 历史最高 180.5745
- 量 比 2.90
- 振 幅 11.06%
- 历史最低 4.31
- 每 手 1
- 风险率 20.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling around 500 points on F...
08-01 22:44
Spotlight on Mr. Cooper Gr: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Mr. Cooper Gr. Our ana...
07-24 03:01
Stocks Jump On Trump's Trade Deal Deluge Ahead Of Big Tech Earnings: What's Moving Markets Wednesday?
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.
07-24 02:35
Mr. Cooper Gr Q2 Adj. EPS $3.13 Misses $3.30 Estimate, Sales $608.000M Miss $671.673M Estimate
Mr. Cooper Gr (NASDAQ:COOP) reported quarterly earnings of $3.13 per share which missed the analyst consensus estimate of $3.30 by 5.09 percent. This is a 24.21 percent increase over earnings of $2.52 per share from the
07-23 19:02
Earnings Scheduled For July 23, 2025
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to repor...
07-23 16:32
UBS Downgrades Mr. Cooper Gr to Neutral, Announces $156 Price Target
UBS analyst Douglas Harter downgrades Mr. Cooper Gr (NASDAQ:COOP) from Buy to Neutral and announces $156 price target.
07-15 20:25
美股大行评级 | 潜在涨幅687%！ 花旗上调新氧科技目标价升至5.5美元，评级"买入"
今日重点评级关注：B. Riley证券：维持内克塔治疗"买入"评级，目标价从60美元升至85美元；Oppenheimer：维持Praxis Precision Medicine"跑赢大市"评级，目标价从97美元升至115美元
07-09 09:26
美股大行评级 | 潜在涨幅336.36%！Canaccord Genuity上调ATAI Life Sciences目标价至12美元，维持"买入"评级
Redburn Atlantic：下调Adobe(ADBE)评级至"卖出"，目标价从420美元降至280美元
07-03 11:01
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Robinhood To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
07-02 01:52
